Inventor · disambiguated record
Michael R. Comeau
Also filed as: COMEAU MICHAEL R
16 granted patents·12 pending applications·191 citations·filing 1995–2025
93Inventor score
Top patents by PatentIndex Score
28 records- 0197US7982016B2Antigen binding proteins capable of binding thymic stromal lymphopoietinAMGEN INC·Filed 2008·Granted Jul 19, 2011·130 cites·16 claims
- 0290US9382318B2ST2 antigen binding proteinsAMGEN INC·Filed 2013·Granted Jul 5, 2016·10 cites·29 claims
- 0388US11059895B2ST2 antigen binding proteinsAMGEN INC·Filed 2019·Granted Jul 13, 2021·2 cites·38 claims
- 0488US10287348B2Antigen binding proteins capable of binding thymic stromal lymphopoietinAMGEN INC·Filed 2016·Granted May 14, 2019·6 cites·12 claims
- 0588US2024368292A1St2 antigen binding proteinsAMGEN INC·Filed 2024·Application pending·0 cites
- 0687US9982054B2ST2 antigen binding proteinsAMGEN INC·Filed 2016·Granted May 29, 2018·4 cites·34 claims
- 0784US9284372B2Antigen binding proteins capable of binding thymic stromal lymphopoietinCOMEAU MICHAEL R·Filed 2012·Granted Mar 15, 2016·6 cites·7 claims
- 0884US8163284B2Methods of treating TSLP-related inflammatory disordersCOMEAU MICHAEL R·Filed 2011·Granted Apr 24, 2012·7 cites·14 claims
- 0978US11965029B2ST2 antigen binding proteinsAMGEN INC·Filed 2021·Granted Apr 23, 2024·0 cites·36 claims
- 1076US2025154241A1Antigen binding proteins capable of binding thymic stromal lymphopoietinAMGEN INC·Filed 2025·Application pending·0 cites
- 1166US2020071393A1Antigen Binding Proteins Capable of Binding Thymic Stromal LymphopoietinAMGEN INC·Filed 2019·Application pending·0 cites
- 1264US10227414B2ST2 antigen binding proteinsAMGEN INC·Filed 2017·Granted Mar 12, 2019·0 cites·45 claims
- 1361US2019203209A1Method of Modulating Fibroblast Accumulation or Collagen DepositionAMGEN INC·Filed 2019·Application pending·0 cites
- 1460US2011052600A1Il-17ra-il-17rb antagonists and uses thereofAMGEN INC·Filed 2009·Application pending·0 cites
- 1557US2006171943A1Compositions and methods of treating fibrotic disordersAMGEN INC·Filed 2006·Application pending·0 cites
- 1655US2014322238A1IL-17RA-IL-17RB Antagonists and Uses ThereofAMGEN INC·Filed 2014·Application pending·0 cites
- 1754US2017081668A1Method of Modulating Fibroblast Accumulation or Collagen DepositionAMGEN INC·Filed 2016·Application pending·0 cites
- 1853US2011117053A1Method of modulating fibroblast accumulation or collagen depositionAMGEN INC·Filed 2011·Application pending·0 cites
- 1952US5726286AIsolated epstein-barr virus BZLF2 proteins that bind MHC class II beta chainsIMMUNEX CORP·Filed 1995·Granted Mar 10, 1998·13 cites·2 claims
- 2050US7214497B2Viral encoded semaphorin protein receptor DNA and polypeptidesIMMUNEX CORP·Filed 2002·Granted May 8, 2007·0 cites·17 claims
- 2150US5925734AIsolated Epstein-Barr virus BZLF2 proteins that bind MHC class II βchainsIMMUNEX CORP·Filed 1997·Granted Jul 20, 1999·5 cites·6 claims
- 2250US2017114140A1Il-17ra-il-17rb antagonists and uses thereofKIRIN-AMGEN INC·Filed 2016·Application pending·0 cites
- 2347US2016208004A1IL-17RA-IL-17RB Antagonists and Uses ThereofAMGEN INC·Filed 2016·Application pending·0 cites
- 2446US6174689B1Viral encoded semaphorin protein receptor DNA and polypeptidesIMMUNEX CORP·Filed 1999·Granted Jan 16, 2001·3 cites·5 claims
- 2543US6187909B1Viral encoded semaphorin protein receptor polypeptidesIMMUNEX CORP·Filed 1999·Granted Feb 13, 2001·2 cites·27 claims
- 2642US2006039910A1Methods and compositions for treating allergic inflammationAMGEN INC·Filed 2005·Application pending·0 cites
- 2738US6130068AViral encoded semaphorin protein receptor DNA and polypeptidesIMMUNEX CORP·Filed 1998·Granted Oct 10, 2000·3 cites·9 claims
- 2831US6562949B1Antibodies to viral encoded semaphorin protein receptor polypeptidesIMMUNEX CORP·Filed 1999·Granted May 13, 2003·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Michael R. Comeau files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →